The 19 billion-dollar startups to watch that are revolutionizing healthcare in 2020

2020 is gearing up to be a pivotal year for healthcare and biotech startups.

In 2019, a handful of health startups went public with valuations above $1 billion, placing them in unicorn territory.

Next year is shaping up to be an even more prolific year, with reports that companies like One Medical could go public by the first quarter of 2020. 

While companies like Tempus and Ginkgo Bioworks and health-insurance startups such as Clover Health and Bright Health added to their war chests, others, like 23andMe and Butterfly Network, maintained their unicorn status without taking on additional funding, according to data provided by PitchBook.

This article was published on December 31, 2019, and has been updated.